Wexford Capital’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Wexford Capital’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,000	Closed	-$1.07M	–	275
2024 Q1	$1.07M	Buy	+50,000	New	+$598K	0.22%	83

Wexford Capital's FUSN Position: Q2 2024 in Review

Wexford Capital sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 50,000 shares — an estimated $1.07M sold.

Wexford Capital first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $1.07M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Wexford Capital reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Wexford Capital sold 50,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $1.07M.
Wexford Capital first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Wexford Capital's Fusion Pharmaceuticals Inc. Common Shares position peaked at $1.07M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Wexford Capital's 13F filing for Q2 2024, filed 14 Aug 2024.